Lauri Ivaska

Lauri Ivaska

@lauriivaska.bsky.social

Paediatrician from Turku, Finland interested in infectious diseases. And football. And Dog Man books. 2024- working in Oxford, UK as a research fellow

369 Followers 108 Following 4 Posts Joined Nov 2024
4 months ago

Absolutely amazing tool 😮 Helps us to discover all the dark corners of our science.

1 1 1 0
4 months ago

Last call 📣 for immunologists interested in a postdoc-project related to immunogenicity of pertussis vaccination:

Submit your application to Qiushui He or to Tapio Lönnberg by 31/10/2025 for a 3-year fellowship position supported by the prestigious MSCA COFUND programme #IMMUFELLOW #uniturku

1 0 0 0
4 months ago
Home - IMMUFELLOW IMMUFELLOW NEWS & EVENTS The Interdisciplinary and Intersectoral Research Fellowship Programme for Future Leaders in Immunology (IMMUFELLOW) is an innovative

Fully funded 3-year SC immunogenomic project related to pertussis vaccine responses at #uniturku (supported by the MSCA COFUND). Apply!

www.linkedin.com/posts/lauri-...

immufellow.fi

1 1 0 1
1 year ago

During this ongoing #pertussis outbreak in Finland, Miettinen et al. observed a considerable increase in the age groups of 10–14 & 15–19 years compared with age distributions in 2019

Macrolide resistance identified in Finland is similar to the one reported from France

IDsky PedsSky 🩺 #PublicHealth

10 4 2 1
1 year ago
Image depicting the table of content of issue 49 in 2024, published 5 December 2024:

Rapid communication
Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024

Outbreaks
Persistence of OXA-48-producing ST-22 Citrobacter freundii in patients and the hospital environment, Paris, France, 2016 to 2022

Systematic Review
Reasons for difficulties in isolating the causative organism during food-borne outbreak investigations using STEC as a model pathogen: a systematic review, 2000 to 2019

Perspective
Cross-sectoral genomic surveillance reveals a lack of insight in sources of human infections with Shiga toxin-producing Escherichia coli, the Netherlands, 2017 to 2023
	
Letter
Vaccinating against the absent: Risks of the B/Yamagata strain in the live attenuated vaccine

Our new issue is available with a special appearance by, again, Escherichia coli

🦠 bit.ly/eus2949 💉

EpiSky #IDSky MicroSky #PublicHealth ⚕️🧪🩺

8 3 1 0
1 year ago
Preview
Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024 Since April 2024, a pertussis epidemic has been ongoing in Finland with 2,215 notified cases by end October. Of them, 30.1% (n = 667) were aged 10–14 years. Of the 462 Bordetella pertussis isolates ch...

Finland has experienced a major pertussis outbreak in 2024. In our report, published today @eurosurveillance.org we describe the epidemic including the first macrolide resistant Bordetella pertussis isolate in our country. Clinical significance still unclear www.eurosurveillance.org/content/10.2...

11 7 0 1